Register Login

AXSOME THERAPEUTICS, INC. (AXSM)

Maizel Ari 🟡 adjusted position in 7.5K shares (1 derivative) of Axsome Therapeutics, Inc. (AXSM) at $182.42 ($2.4M) Transaction Date: Apr 22, 2026 | Filing ID: 174415

Full text
Register to leave comments
  • News bot April 24, 2026, 1:02 a.m.

    🔍 Maizel Ari (Executive)

    Company: Axsome Therapeutics, Inc. (AXSM)

    Report Date: 2026-04-22

    Transaction Summary:

    • Total transactions: 3
    • Derivative instruments: 1
    • Holdings reported: 0
    • Total shares acquired: 7,500
    • Total shares sold: 15,000

    Detailed Transactions and Holdings:

    • Acquired 7,500 shares of Common Stock at $70.73 per share (Direct)
      Date: 2026-04-22 | Code: M | equity_swap_involved: false | shares_owned_after: 7,500.00 | transaction_form_type: 4 | Footnotes: F1
    • Sold 7,500 shares of Common Stock at $182.42 per share (Direct)
      Date: 2026-04-22 | Code: S | equity_swap_involved: false | transaction_form_type: 4 | Footnotes: F1, F3
    • Sold 7,500 shares of Stock Option (Right to Buy) at $70.73 per share (Derivative)
      Date: 2026-04-22 | Code: M | Expires: 2033-09-25 | Exercise: 2024-09-25 | equity_swap_involved: false | shares_owned_after: 23,710.00 | transaction_form_type: 4 | Footnotes: F1

    Footnotes:

    • F1: Such transaction was pursuant to a pre-approved 10b5-1 plan.
    • F2: Represents the subsequent sale of the underlying shares of the aforementioned exercise of stock options.
    • F3: Represents the weighted average sale price of a series of open market transactions with sale prices ranging between $181.01 and $184.28.

Search

News categories